Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-005288
Filing Date
2025-03-12
Accepted
2025-03-12 19:26:11
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 7483
  Complete submission text file 0001062993-25-005288.txt   8999
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTURY THERAPEUTICS, INC. 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address
Carr Douglas (Reporting) CIK: 0001867173 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40498 | Film No.: 25733326